Perioperative Nivolumab and Chemotherapy in Stage III NSCLC
1. The pathological complete response rate for the experimental group was improved compared to the control group. 2. Progression-free survival ...
1. The pathological complete response rate for the experimental group was improved compared to the control group. 2. Progression-free survival ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.